References
- 1. Zelger BG, Zelger BWH. Myofibroblastic dermatofibroma: a cutaneous variant of intranodal myofibroblastoma. Am J Dermatopathol 1996;18:441.
- 2. Zelger B, Zelger G, Burgdorf WHC. Dermatofibroma: a critical evaluation. Int J Surg Pathol 2004;12:333-44.
- 3. Eyden B. Fibroblast phenotype plasticity: relevance for understanding heterogenity in „fibroblastic“ tumors. Ultrastruct Pathol 2004;28:307-19.
- 4. Fisher C. Myofibroblastic malignancies. Adv Anat Pathol 2004;11:190-201.
- 5. Zelger BG, Sidoroff A, Zelger B. Combined dermatofibroma: co-existence of two or more variant patterns in a single lesion. Histopathology 2000;36:529-39.
- 6. Eyden B. The myofibroblast: a study of normal, reactive and neoplastic tissues, with an emphasis on ultrastructure. part 2 - tumours and tumour-like lesions. J Submicrosc Cytol Pathol 2005;37:231-96.
- 7. Fletcher CD. Myofibroblastic tumours: an update. Verh Deutsc Ges Pathol 1998;82:75-82.
- 8. Calonje E. Is cutaneous benign fibrous histiocytoma (dermatofibroma) a reactive inflammatory process or neoplasm? Histopathology 2000;37:278-80.
- 9. Eyden B. Electron microscopy in the study of myofibroblastic lesions. Semin Diagn Pathol 2003;20:13-24.
- 10. Zelger BG, Zelger B. Dermatofibroma (fibrous histiocytoma): An inflammatory or neoplastic disorder? Histopathology 2001;38:379-81.
- 11. Zelger BW, Zelger BG, Rappersberger K. Prominent myofibroblastic differentiation: a pitfall in the diagnosis of dermatofibroma. Am J Dermatopathol 1997;19:138-46.
- 12. Eyden BP, Harris M, Greywoode GJ, Christensen L, Banerjee SS. Intranodal myofibroblastoma: report of a case. Ultrastrucl Pathol 1996;20:79-88.
- 13. Eyden BP, Ponting J, Defining the myofibroblast: normal tissues, with special reference to the stromal cells of Wharton’s jelly in human umbilical cord. J Submicrosc Cytol Pathol 1994;26:347-55.
- 14. Dishop MK, Warner BW, Dehner LP, et al. Successful treatment of inflammatory myofibroblastic tumor with malignanttransformation by surgical resection and chemotherapy. J Pediatr Hematol Oncol 2003;25:153-8.